Related Experiment Video
Updated: May 26, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Complete heart block during potassium therapy in thyrotoxic periodic paralysis
Huei-Fang Wang1, Shih-Ching Tsai, Ming-Sung Pan
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Saint Mary's Hospital, Luodong, Yilan, Taiwan.
Thyrotoxic periodic paralysis (TPP) can cause dangerous drops in potassium levels, even with potassium chloride (KCl) treatment, leading to severe heart block. Prompt recognition and management of this paradoxical hypokalemia are crucial for patient survival.
Area of Science:
- Endocrinology
- Cardiology
- Emergency Medicine
Background:
- Cardiac dysrhythmias are common in thyrotoxic periodic paralysis (TPP).
- High-degree atrioventricular (AV) block with cardiogenic shock during KCl supplementation is rare in TPP.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
